دورية أكاديمية

Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021

التفاصيل البيبلوغرافية
العنوان: Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021
المؤلفون: Rao, V. Koneti, Webster, Sharon *, Sediva, Anna *, Plebani, Alessandro *, Schuetz, Catharina *, Shcherbina, Anna *, Dalm, Virgil A.S.H. *, Trizzino, Antonino *, Zharankova, Yulia *, Kulm, Elaine *, Orpia, Alanvin *, Chirombo Kluczynski, Lavenda *, Körholz, Julia *, Lougaris, Vassilios *, Rodina, Yulia *, Kucher, Klaus *, Radford, Kath *, Bradt, Jason *, Uzel, Gulbu *
المصدر: In Blood 15 November 2022 140 Supplement 1:1643-1645
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood-2022-160334